| scholarly article | Q13442814 |
| P50 | author | Alejandro Couce | Q57016708 |
| Jesus Blazquez | Q68273789 | ||
| P2093 | author name string | Alexandro Rodríguez-Rojas | |
| P2860 | cites work | Adaptation to the fitness costs of antibiotic resistance in Escherichia coli | Q73792447 |
| Population extinction and the genetics of adaptation | Q81709194 | ||
| Conditional gene genealogies under strong purifying selection | Q81983203 | ||
| Estimating mutation rates in low-replication experiments | Q84517623 | ||
| Bypass of genetic constraints during mutator evolution to antibiotic resistance | Q86832377 | ||
| Quantifying the adaptive potential of an antibiotic resistance enzyme | Q21563371 | ||
| Mutations of Bacteria from Virus Sensitivity to Virus Resistance | Q24533278 | ||
| Clonal interference and the periodic selection of new beneficial mutations in Escherichia coli | Q24545892 | ||
| The fitness costs of antibiotic resistance mutations | Q26825334 | ||
| Cancer evolution: mathematical models and computational inference | Q27002537 | ||
| Interactions among DNA ligase I, the flap endonuclease and proliferating cell nuclear antigen in the expansion and contraction of CAG repeat tracts in yeast | Q27939439 | ||
| Common Virulence Factors for Bacterial Pathogenicity in Plants and Animals | Q28292772 | ||
| Soft sweeps II--molecular population genetics of adaptation from recurrent mutation or migration | Q28300630 | ||
| The distribution of fitness effects of beneficial mutations in Pseudomonas aeruginosa | Q28474903 | ||
| Interplay in the selection of fluoroquinolone resistance and bacterial fitness | Q28475870 | ||
| Selection of resistant bacteria at very low antibiotic concentrations | Q28479239 | ||
| The glycerol-3-phosphate permease GlpT is the only fosfomycin transporter in Pseudomonas aeruginosa | Q28492495 | ||
| nfxB as a novel target for analysis of mutation spectra in Pseudomonas aeruginosa | Q28533745 | ||
| Measurement of Diversity | Q29303177 | ||
| Positive epistasis drives the acquisition of multidrug resistance | Q33486486 | ||
| Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype | Q33604942 | ||
| Sorting out mutation rates | Q33679426 | ||
| Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure | Q33756688 | ||
| Determining mutation rates in bacterial populations | Q33803752 | ||
| Progress of a half century in the study of the Luria-Delbrück distribution | Q33806584 | ||
| Initial mutations direct alternative pathways of protein evolution | Q33847781 | ||
| Evolutionary dynamics of intratumor heterogeneity. | Q33867413 | ||
| Drug resistance in cancer: principles of emergence and prevention | Q33892278 | ||
| The sampling distribution of disease-associated alleles. | Q33971579 | ||
| Delayed Phenotypic Expression of Spontaneous Mutations in Escherichia Coli | Q33975019 | ||
| Molecular basis of base substitution hotspots in Escherichia coli | Q34183770 | ||
| The sampling theory of selectively neutral alleles | Q34216106 | ||
| Population biology of multihost pathogens | Q34250517 | ||
| Accumulation of driver and passenger mutations during tumor progression | Q34276850 | ||
| A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma | Q34418880 | ||
| Genetic clonal diversity predicts progression to esophageal adenocarcinoma | Q34505745 | ||
| The biological cost of mutational antibiotic resistance: any practical conclusions? | Q34554396 | ||
| Evolution of Escherichia coli rifampicin resistance in an antibiotic-free environment during thermal stress | Q34596522 | ||
| Compensatory evolution in rifampin-resistant Escherichia coli | Q34610970 | ||
| Evolutionary triage governs fitness in driver and passenger mutations and suggests targeting never mutations. | Q34662452 | ||
| A practical guide to measuring mutation rates in antibiotic resistance | Q34746116 | ||
| Intratumor heterogeneity in evolutionary models of tumor progression | Q35065519 | ||
| The population dynamics of antimicrobial chemotherapy. | Q35132378 | ||
| Mutation of the maturase lipoprotein attenuates the virulence of Streptococcus equi to a greater extent than does loss of general lipoprotein lipidation | Q35220411 | ||
| Biological costs and mechanisms of fosfomycin resistance in Escherichia coli | Q35685710 | ||
| In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients | Q36313798 | ||
| Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives | Q36386428 | ||
| WHEN DOES EVOLUTION BY NATURAL SELECTION PREVENT EXTINCTION? | Q36395570 | ||
| Evolutionary approaches to prolong progression-free survival in breast cancer | Q36476358 | ||
| SIRT1 contributes in part to cisplatin resistance in cancer cells by altering mitochondrial metabolism | Q37002755 | ||
| Predicting antibiotic resistance | Q37002813 | ||
| The dynamics of genetic draft in rapidly adapting populations | Q37269691 | ||
| Fitness benefits in fluoroquinolone-resistant Salmonella Typhi in the absence of antimicrobial pressure | Q37379658 | ||
| Early antibiotic treatment failure | Q37549380 | ||
| The population genetics of commensal Escherichia coli | Q37692844 | ||
| Antibiotic resistance and its cost: is it possible to reverse resistance? | Q37704177 | ||
| Intra-tumor heterogeneity: lessons from microbial evolution and clinical implications | Q38165448 | ||
| Antibiotics in the environment. | Q38197282 | ||
| Microbiological effects of sublethal levels of antibiotics. | Q38214805 | ||
| Use of the rpoB gene to determine the specificity of base substitution mutations on the Escherichia coli chromosome | Q38355288 | ||
| A new practical guide to the Luria-Delbrück protocol | Q38586289 | ||
| Predators increase the risk of catastrophic extinction of prey populations | Q39121667 | ||
| Increased survival of antibiotic-resistant Escherichia coli inside macrophages | Q39254914 | ||
| Resistance Mutations in gyrA and parC are Common in Escherichia Communities of both Fluoroquinolone-Polluted and Uncontaminated Aquatic Environments | Q40860093 | ||
| Selective compartments for resistant microorganisms in antibiotic gradients | Q40885917 | ||
| On fluctuation analysis: a new, simple and efficient method for computing the expected number of mutants | Q41645462 | ||
| Interpretations arising from Wrightian and Malthusian fitness under strong frequency dependent selection. | Q41886122 | ||
| Methods for determining spontaneous mutation rates | Q42620101 | ||
| Evolutionary rescue in a changing world | Q43688807 | ||
| Analysis of mutational resistance to trimethoprim in Staphylococcus aureus by genetic and structural modelling techniques | Q46041950 | ||
| Resistance in the environment. | Q51657447 | ||
| Source-sink dynamics shape the evolution of antibiotic resistance and its pleiotropic fitness cost. | Q51705053 | ||
| Can sensitivity to cytotoxic chemotherapy be predicted by biomarkers? | Q59274014 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | genetic diversity | Q585259 |
| P1104 | number of pages | 12 | |
| P304 | page(s) | 1369-1380 | |
| P577 | publication date | 2016-05-10 | |
| P1433 | published in | Genetics | Q3100575 |
| P1476 | title | Determinants of Genetic Diversity of Spontaneous Drug Resistance in Bacteria | |
| P478 | volume | 203 |
Search more.